This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2023 Jun 25;24(13):10633.

doi: 10.3390/ijms241310633.

Chronic Liver Disease: Latest Research in Pathogenesis, Detection and Treatment

Silvia De Siervi¹, Stefania Cannito², Cristian Turato¹

Affiliations

Affiliations

¹ Department of Molecular Medicine, University of Pavia, 27100 Pavia, Italy.
² Department of Clinical and Biological Sciences, University of Turin, 10125 Turin, Italy.

PMID: 37445809
PMCID: PMC10341817
DOI: 10.3390/ijms241310633

Editorial

Chronic Liver Disease: Latest Research in Pathogenesis, Detection and Treatment

Silvia De Siervi et al. Int J Mol Sci. 2023.

. 2023 Jun 25;24(13):10633.

doi: 10.3390/ijms241310633.

Authors

Silvia De Siervi¹, Stefania Cannito², Cristian Turato¹

Affiliations

¹ Department of Molecular Medicine, University of Pavia, 27100 Pavia, Italy.
² Department of Clinical and Biological Sciences, University of Turin, 10125 Turin, Italy.

PMID: 37445809
PMCID: PMC10341817
DOI: 10.3390/ijms241310633

Abstract

Chronic liver disease (CLD) is a major global health threat and has emerged as a leading cause of human death [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

[The clinical picture, diagnosis and treatment of chronic liver diseases (a lecture)].
Burchinskiĭ GI. Burchinskiĭ GI. Lik Sprava. 1993 Jul;(7):14-23. Lik Sprava. 1993. PMID: 8209525 Russian.
Zinc supplementation and its benefits in the management of chronic liver disease: An in-depth literature review.
Bloom A, Bloom S, Silva H, Nicoll AJ, Sawhney R. Bloom A, et al. Ann Hepatol. 2021 Nov-Dec;25:100549. doi: 10.1016/j.aohep.2021.100549. Epub 2021 Oct 3. Ann Hepatol. 2021. PMID: 34614431 Review.
Treatment for restless legs syndrome secondary to chronic liver disease: a case report.
Oguri T, Sugiyama H, Hamano T, Tachibana N. Oguri T, et al. Intern Med. 2012;51(8):933-4. doi: 10.2169/internalmedicine.51.6853. Epub 2012 Apr 15. Intern Med. 2012. PMID: 22504254
Classification and treatment of chronic active liver disease.
Geall MG, Schoenfield LJ, Summerskill WH. Geall MG, et al. Gastroenterology. 1968 Dec;55(6):724-9. Gastroenterology. 1968. PMID: 5727785 Clinical Trial. No abstract available.
Matrix metalloproteinases and their inhibitors as markers of inflammation and fibrosis in chronic liver disease (Review).
Consolo M, Amoroso A, Spandidos DA, Mazzarino MC. Consolo M, et al. Int J Mol Med. 2009 Aug;24(2):143-52. doi: 10.3892/ijmm_00000217. Int J Mol Med. 2009. PMID: 19578787 Review.

See all similar articles

Cited by

Advances, challenges and future applications of liver organoids in experimental regenerative medicine.
Gong D, Mo J, Zhai M, Zhou F, Wang G, Ma S, Dai X, Deng X. Gong D, et al. Front Med (Lausanne). 2025 Jan 24;11:1521851. doi: 10.3389/fmed.2024.1521851. eCollection 2024. Front Med (Lausanne). 2025. PMID: 39927267 Free PMC article. Review.
Comprehensive review of leonurine: harnessing its therapeutic potential for chronic diseases.
Manickasamy MK, Daimary UD, Sajeev A, Abbas M, Alqahtani MS, Abdulhammed A, Kunnumakkara AB. Manickasamy MK, et al. Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 9. doi: 10.1007/s00210-025-04087-x. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40202674 Review.
Aging, ROS, and cellular senescence: a trilogy in the progression of liver fibrosis.
Almalki WH, Almujri SS. Almalki WH, et al. Biogerontology. 2024 Nov 15;26(1):10. doi: 10.1007/s10522-024-10153-3. Biogerontology. 2024. PMID: 39546058 Review.
AMPK agonist AICAR ameliorates maternal hepatic lipid metabolism disorder, inflammation, and fibrosis caused by PM_2.5 exposure during pregnancy.
Wan T, Chen Z, Li J, Yuan X, Zheng M, Qin L, Zhang L, Hou T, Liu C, Li R. Wan T, et al. Sci Rep. 2025 Mar 13;15(1):8689. doi: 10.1038/s41598-025-93395-6. Sci Rep. 2025. PMID: 40082541 Free PMC article.
Temporal Trends and Disparities in Chronic Liver Disease Mortality: An Analysis Using National Center for Health Statistics (NCHS) Data Ranging From 1999 to 2023.
Ezeamii VC, Arinzechi CI, Oghotuoma OO, Umoudoh U, Adebayo AA, Nnabude OH, Ajani T, Ayinde B, Anyaorah C, Ojukwu G. Ezeamii VC, et al. Cureus. 2025 May 12;17(5):e83957. doi: 10.7759/cureus.83957. eCollection 2025 May. Cureus. 2025. PMID: 40510081 Free PMC article.

See all "Cited by" articles

References

1. Cheemerla S., Balakrishnan M. Global Epidemiology of Chronic Liver Disease. Clin. Liver Dis. 2021;17:365–370. doi: 10.1002/cld.1061. - DOI - PMC - PubMed
1. Yin X., Guo X., Liu Z., Wang J. Advances in the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease. Int. J. Mol. Sci. 2023;24:2844. doi: 10.3390/ijms24032844. - DOI - PMC - PubMed
1. Cannito S., Dianzani U., Parola M., Albano E., Sutti S. Inflammatoryprocessesinvolved in NASH-relatedhepatocellular carcinoma. Biosci. Rep. 2023;43:BSR20221271. doi: 10.1042/BSR20221271. - DOI - PMC - PubMed
1. Winarto J., Song D.G., Pan C.H. The Role of Fucoxanthin in Non-Alcoholic Fatty Liver Disease. Int. J. Mol. Sci. 2023;24:8203. doi: 10.3390/ijms24098203. - DOI - PMC - PubMed
1. Qiao A., Ma W., Jiang Y., Han C., Yan B., Zhou J., Qin G. Hepatic Sam68 Regulates Systemic Glucose Homeostasis and Insulin Sensitivity. Int. J. Mol. Sci. 2022;23:11469. doi: 10.3390/ijms231911469. - DOI - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information